Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

According to the Texas State Board of Pharmacy, state law does allow pharmacists to substitute a brand-name medication with a generic version as long as the patient doesn't refuse it or the doctor ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...

Chinese authorities defended the quality of homegrown generic medicines after groups of doctors complained of their efficacy ...

Your local pharmacy might be the next front in Donald Trump’s trade war. The president has in recent weeks promised to impose tariffs on all foreign-made medications, a move intended to encourage drug ...